| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
07-28-2017, 12:56 PM
|
#7 | ||
|
|||
|
Member
|
I wanted to share more information on the new Phase IIa clinical trial funded by our Foundation (MJFF) to test the safety and tolerability of nilotinib in Parkinson’s disease. The trial will investigate the potential of repurposing nilotinib (which many in the patient community know is an FDA-approved treatment for cancer of the white blood cells) in Parkinson’s disease.
You can read more details on the nilotinib trial on our blog and download our guide on what patients and families should know about repurposed therapies. -Debi |
||
|
 Reply With Quote
|
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Another double-blind, clinical study of Nilotinib for Parkinson's | Parkinson's Disease | |||
| Nilotinib Parkinson Webinar! Very exciting! | Parkinson's Disease | |||
| Nilotinib Parkinson Trial to begin this summer! | Parkinson's Disease | |||
| Michael Fox Partners to Assess Clinical Development of Nilotinib in Parkinson's | Parkinson's Disease | |||
| Compassionate use of Nilotinib for treating Parkinson's & Lewy Body Disease Patients | Parkinson's Disease | |||
Repurposing Nilotinib in Parkinson’s
Threaded Mode